| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |